Andy Long

Andy Long Email and Phone Number

EVP and CEO, Products and Healthcare Services @ Owens & Minor
Richmond, VA, US
Andy Long's Location
Greater Richmond Region, United States, United States
About Andy Long

Dynamic executive leader of global organizations across life sciences, pharma and medical device sectors with experience in manufacturing, research, distribution and service industries at Fortune 500 & private equity companies with a track record of achieving improved growth and profitability• Financial leadership experience at companies with a strong reputation for developing talent (Abbott Laboratories, Emerson Electric, Eaton and Thermo Fisher)• Experience in manufacturing (cost accounting, inventory, capex decision support), commercial (commission plans, productivity metrics) and negotiating large contracts (pricing, incentives, terms)• Diverse experience in multiple industries (Life Science, Industrial, Bio-Pharma)• Knowledge of multiple business models (manufacturing, distribution, research and contract services) • Multi-site, global controllership responsibility, SOX, compliance and external audit • IPO experience raising $0.7B of capital• Tax, Treasury, Investor Relations (IR) and Business Development support• M&A valuation, due-diligence and integration expertise• Software implementation including ERP systems and Hyperion enterprise• Supply chain management (working capital improvement, sales growth, cost reduction)• Passion for talent management and creation of high performing finance teams (performance excellence)

Andy Long's Current Company Details
Owens & Minor

Owens & Minor

View
EVP and CEO, Products and Healthcare Services
Richmond, VA, US
Andy Long Work Experience Details
  • Owens & Minor
    Evp And Ceo, Products And Healthcare Services
    Owens & Minor
    Richmond, Va, Us
  • Owens & Minor
    Evp And Ceo, Products And Healthcare Services
    Owens & Minor Oct 2022 - Present
    Mechanicsville, Va, Us
  • Owens & Minor
    Evp/Cfo
    Owens & Minor 2019 - Oct 2022
    Mechanicsville, Va, Us
  • Insys Therapeutics, Inc.
    Chief Executive Officer
    Insys Therapeutics, Inc. 2019 - 2019
    Publicly traded (NASDAQ: INSY) Specialty Pharmaceutical Company
  • Insys Therapeutics, Inc.
    Chief Financial Officer
    Insys Therapeutics, Inc. 2017 - 2019
    Publicly traded (NASDAQ: INSY) Specialty Pharmaceutical Company Responsible for investor relations, treasury, tax, FP&A, controllership, SEC reporting and information technology
  • Patheon
    Senior Vice President, Global Finance
    Patheon 2015 - 2017
    Waltham, Massachusetts, Us
    $2B private equity backed provider of contract development and manufacturing services to bio-pharma industry Reported to CFO, holding full financial responsibility for all global manufacturing sites. Oversaw corporate financial planning and analysis and provided financial support for corporate development, M&A, and investor relations (IR). • Raised $0.7B in capital by supporting one of Wall Street’s largest successful IPO’s of 2016.• Partnered with tax group, structuring tax efficient customer agreement, reducing tax liability by $40M.• Performed valuation, coordinated due diligence and integrated state-of-the-art API manufacturing facility.• Launched Hyperion Planning enterprise software, delivering project on time and on budget.• Envisioned and introduced enhanced planning and forecasting system through the utilization of data-driven metrics and analytics, improving performance and increasing forecast accuracy.• Transformed finance team by outsourcing back-office functions and upgrading 40% of leadership roles.• Collaborated with treasury to reduce DSO, driving lower working capital and improving cash flow.
  • Thermo Fisher Scientific
    Vice President, Global Finance/Fisher Scientific (Group Cfo)
    Thermo Fisher Scientific 2012 - 2015
    Waltham, Ma, Us
    Thermo Fisher Scientfic is a $17B global supplier of life-science tools, advancing scientific knowledge and enabling drug discoveryProvided management and financial operations direction for global FP&A, controllership, M&A, and strategic planning initiatives for the $5B+ legacy Fisher Scientific distribution business. In addition, served as financial business partner to the company’s Chief Commercial Officer (CCO) and global accounts team. Led global finance team of 400+ employees including shared service centers.• Structured comprehensive commercial contracts ranging in size from $5M to $200M in annual revenue driving organic growth 2X market.• Identified $30M supplier rebate opportunity as part of European transformation.• Drove pricing and cost actions offsetting $40M of FX profitability headwinds from stronger US$.• Named Steering Committee member with responsibility for overseeing the company’s largest ERP implementation enabling over $25M/year of profit improvement.• Designed, implemented and exported comprehensive finance talent-management framework fostering enhanced career development which cut turn-over in half to 4%.• Championed company-wide Commercial Finance Excellence Team identifying and implementing best practices to accelerate organic growth.
  • Thermo Fisher Scientific
    Vice President, Global Finance/Laboratory Products (Group Cfo)
    Thermo Fisher Scientific 2012 - 2012
    Waltham, Ma, Us
    Headed all financial planning, reporting and analysis of a $2B global group tasked with developing, manufacturing and distributing laboratory equipment and consumables used to conduct research in a laboratory environment.• Expanded accountability to direct the Sales Operations team in delivering sales analytics to support global commercial team; managing operations related to pricing, customer growth/profitability, commissions, and sales force productivity.• Implemented new capital project review process reducing approval cycle time and capital spending by 10%.
  • Thermo Fisher Scientific
    Vice President, Global Finance/Fisher Research Products (Division Cfo)
    Thermo Fisher Scientific 2009 - 2012
    Waltham, Ma, Us
    Controlled all global financial aspects of the $4B distribution business - company’s largest division. • Negotiated 2 exclusive supplier contracts valued at $260M annual revenue.• Spearheaded $125M acquisition by identifying synergies, handling due diligence and integrating operations.• Analyzed entrance into India market finding opportunities to improve operating margins by 750 bps.• Supervised multiple cross-company process improvement teams uncovering innovative ways to improve price realization and enhancing Quarterly Business Review presentations.
  • Thermo Fisher Scientific
    Vice President, Global Finance & It/Life Science Research (Business Unit Cfo)
    Thermo Fisher Scientific 2006 - 2009
    Waltham, Ma, Us
    Hired to manage global financial planning, reporting and analysis for business comprised of leading product lines including Dharmacon® (RNAi), Pierce® (protein analysis), ABgene® (PCR), Hyclone® (Media/Sera), and Cellomics® (High Content Analysis).• Transformed 7 independently run businesses to function as 1 unified organization by harmonizing IT platforms, rationalizing sales force and distribution channels, realigning organization structures and closing facilities enabling an 800-bps expansion in operating margins.• Directed financial aspects of 2 acquisitions overseeing valuation, due diligence, and integration.
  • Cambrex
    Vice President, Global Finance & Supply Chain Operations
    Cambrex 2001 - 2006
    East Rutherford, New Jersey, Us
    $0.5B innovative life sciences company providing products and services to accelerate drug discoveryCharged with directing all global financial planning, reporting and analysis for multi-site, global organization. Administered global supply chain management including comprehensive “quote-to-cash” process consisting of order entry, customer service, sales and operations planning (S&OP), purchasing, inventory control, warehousing, distribution, QC testing and IT.• Acted as key contributor in the creation of a Cell Therapy Contract Manufacturing Organization (CMO) start-up by forming business plans, structuring customer contracts and creating financial models justifying $14M in capital investment.• Drove supply chain improvements reducing raw material inventory by 25%, inventory loss expense by 75%, and supply chain headcount by 8% despite revenue growth of >20%.• Advanced cost structure visibility by creating product line P&Ls, implementing Hyperion Enterprise software and improving cost allocation methodologies leading to divestiture of low-margin business.• Divested low-margin business, negotiating terms, managing due diligence and coordinating post-divestiture reorganization.• Sharpened focus on supplier partnerships by establishing Supplier Day and Supplier Technical Conferences driving $4M/year in savings while improving supplier quality and on-time-delivery.• Reduced DSO from 77 to 45 days over 19-month period and overdue A/R from $2.4M to $.1M with a 96% collection rate increasing operating profit by $2.3M.
  • Eaton
    Division Controller, Fluid Power
    Eaton 1998 - 2001
    Dublin, Ireland, Ie
    Business partner to division presidentGlobal P&L responsiblity for both Mobile and Industrial Hydrualics divisionsIntegrated Aeroquip-Vickers acquistion ($600M revenue)
  • Emerson Electric
    Director, Finance
    Emerson Electric 1996 - 1998
    St. Louis, Mo, Us
  • Abbott Laboratories
    Multiple Financial Leadership Roles
    Abbott Laboratories 1987 - 1996
    Abbott Park, Illinois, Us

Andy Long Skills

Managerial Finance Finance Management Strategy Acquisition Integration Mergers And Acquisitions Process Improvement Competitive Analysis Forecasting Biotechnology Financial Modeling Business Partner Financial Analysis Business Strategy Business Process Improvement Start Ups Life Sciences Due Diligence Mergers Lifesciences Market Research Pricing Financial Reporting Supply Chain Management P&l Responsibility Corporate Finance Cost And Overhead Reduction Strategic Leadership Financial Planning Sox Compliance Financial Forecasting Software Implementation Corporate Development Talent Management Sales And Operations Planning M&a Activities Change Agent

Andy Long Education Details

  • Northwestern University - Kellogg School Of Management
    Northwestern University - Kellogg School Of Management
    Operations Management
  • Indiana University Bloomington
    Indiana University Bloomington
    Finance

Frequently Asked Questions about Andy Long

What company does Andy Long work for?

Andy Long works for Owens & Minor

What is Andy Long's role at the current company?

Andy Long's current role is EVP and CEO, Products and Healthcare Services.

What is Andy Long's email address?

Andy Long's email address is al****@****srx.com

What is Andy Long's direct phone number?

Andy Long's direct phone number is +160291*****

What schools did Andy Long attend?

Andy Long attended Northwestern University - Kellogg School Of Management, Indiana University Bloomington.

What skills is Andy Long known for?

Andy Long has skills like Managerial Finance, Finance, Management, Strategy, Acquisition Integration, Mergers And Acquisitions, Process Improvement, Competitive Analysis, Forecasting, Biotechnology, Financial Modeling, Business Partner.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.